In Prevention of organ rejection in transplant patients Raparen 1mg Injection is used with other medications to prevent organ transplant rejection. Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc. This medicine reduces the activity of a person's own immune system and prevents any such rejection.
It is not known whether it is safe to consume alcohol with Raparen 1mg Injection. Please consult your doctor.
Raparen 1mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Raparen 1mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Raparen 1mg Injection does not usually affect your ability to drive.
Raparen 1mg Injection is safe to use in patients with kidney disease. No dose adjustment of Raparen 1mg Injection is recommended.
Raparen 1mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Raparen 1mg Injection may be needed. Please consult your doctor. Dose adjustment is not recommended in patients with mild to moderate liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Panacea Biotec Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Anthem Biopharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biocon || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pfizer Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Claris Lifesciences Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alniche Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)